Glycogen Storage Disease Type Ia (GSDIa) Disease Monitoring Program
Part of paid clinical trials in Orange, California.
- Sponsor
- Ultragenyx Pharmaceutical Inc
- Study ID
- NCT06636383
- Status
- Recruiting
Conditions
- Glycogen Storage Disease Type Ia
Eligibility Criteria
- Sex
- ALL
- Age
- 2 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- No Intervention — OTHERNo investigational/study product will be administered in this DMP.
Study Details
The main objective of this observational study is to evaluate the long-term safety and effectiveness of DTX401 for at least 10 years after DTX401 administration.
Key Dates
- Start date
- Nov 4, 2024
- Status verified
- May 2026
- Primary completion
- Dec 31, 2036
- Completion
- Dec 31, 2036
Study Design
- Enrollment
- 140 participants (estimated)
Arms
- Arm: Group 1: DTX401 in Prior Clinical StudyPatients administered DTX401(pariglasgene brecaparvovec), full or partial dose, in prior clinical study involving DTX401
- Arm: Group 2: DTX401 in Post-Marketing SettingPatients administered prescribed DTX401(pariglasgene brecaparvovec), full or partial dose, in a post-marketing setting
Primary Outcome Measure
Incidence and Severity of Serious Adverse Events (SAEs) Assessed as Related to DTX401 by the Investigator [ Time Frame: 10 Years ]
Central Contacts
- Patients Contact: Trial Recruitment1-888-756-8657
- HCPs Contact: Medical Information1-888-756-8657
Locations (9)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Children's Hospital of Orange County | Orange | California | 92868 | - |
| Children's Hospital Colorado | Denver | Colorado | 80045 | - |
| University of Connecticut Health Center | Hartford | Connecticut | 06106 | - |
| University of Michigan | Ann Arbor | Michigan | 48109 | - |
| Duke University Medical Center | Durham | North Carolina | 27710 | - |
| The Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | - |
| Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 | - |
| University of Texas Health Science Center at Houston | Houston | Texas | 77030 | - |
| Primary Children's Hospital | Salt Lake City | Utah | 84108 | - |
Find similar trials in Orange, CA
Related Studies
- A Phase 1/2, Dose-Exploration Study to Evaluate the Safety and Efficacy of BEAM-301 in Patients With Glycogen Storage Disease Type Ia (GSDIa)PHASE1/PHASE2 · Recruiting · Beam Therapeutics Inc. · Orange, California
- Accuracy of Lactate Meter in GSDIaRecruiting · Connecticut Children's Medical Center · Hartford, Connecticut
- Accuracy of Home Lactate Meter and Accu-chek Glucometer in Patients With Glycogen Storage DiseaseRecruiting · Connecticut Children's Medical Center · Hartford, Connecticut